|
|
|
|
benign prostatic hyperplasia
BPH. A benign (noncancerous) condition in which an overgrowth of prostate tissue pushes against the urethra and the bladder, blocking the flow of urine. Also called benign prostatic hypertrophy. (National Cancer Institute)
AEterna Zentaris Announces Cetrorelix Development with Solvay ... Mar 16, 2005
...fertilization under the brand name Cetrotide®, and has successfully completed a broad Phase II program in endometriosis and benign prostatic hyperplasia (BPH ... Yahoo News (press release)
Spectrum Pharmaceuticals Announces Presentation of EOquin(TM) ... Mar 16, 2005
...with the potential to treat hormone-dependent cancers as well as benign proliferative disorders, such as benign prostatic hyperplasia and endometriosis. ... PR Newswire (press release)
GTx, Inc.'s Second SARM Shows Phase I Clinical Safety Mar 15, 2005
...highlights the untapped potential of these novel drugs for the treatment of many other men's health diseases, such as benign prostatic hyperplasia (BPH), male ... PR Newswire (press release)
Nymox Reports 2004 Financial Results Mar 15, 2005
Pharmacy stores across the US. Nymox is developing NX-1207, a novel treatment for benign prostatic hyperplasia. NX-1207 has shown ... Business Wire (press release),
Biotech Takes a Hit in February Mar 11, 2005
The company's initial focus is on the treatment of cancer and benign prostatic hyperplasia. There was big news out of Washington this month. ... Yahoo News (press release)
New Reports and Studies Highlight Importance of Alzheimer's ... Mar 11, 2005
The Company has successfully completed two US Phase 1 and Phase 1-2 clinical trials for NX-1207, its drug for benign prostatic hyperplasia (BPH). ... Business Wire (press release),
NATUROPATHY: Keeping your prostate healthy Feb 21, 2005
...large as a grapefruit. Prostate enlargement or benign prostatic hyperplasia (BPH) usually begins after the age of 35. By 50, more ... New Straits Times,
GTx, Inc. to Present at the 25th Annual SG Cowen Health Care ... Mar 8, 2005
...generated from its own discovery program which includes the specific product candidates, prostarine, a SARM for benign prostatic hyperplasia (BPH), and ... PR Newswire (press release)
Insulin Abnormalities Linked to Alzheimer's Disease by Researchers ... Mar 7, 2005
...applications. The Company is conducting pivotal Phase II clinical trials for NX-1207, a new drug for benign prostatic hyperplasia (BPH). ... Business Wire (press release),
Laserscope Reports Record Revenues and Earnings for 2004 Fourth ... Mar 3, 2005
...our urology business in 2002, global adoption of the PVP procedure using the GreenLight(TM) laser system for treatment for Benign Prostatic Hyperplasia, or BPH ... PR Newswire (press release)
New BASS Sponsor Cialis(R) (tadalafil) Showcases Interactive ... Mar 2, 2005
...is working to develop treatments for serious unmet medical conditions such as chronic obstructive pulmonary disease, benign prostatic hyperplasia, cancer and ... PR Newswire (press release)
American Medical Systems Holds Special Shareholders' Meeting ... Mar 4, 2005
Minnetonka, Minnesota is a diversified supplier of medical devices and procedures to cure erectile dysfunction, benign prostatic hyperplasia, incontinence, and ... Business Wire (press release),
Nymox Expands Large Patent Portfolio; Nymox Pharmaceutical -NASDAQ ... Feb 23, 2005
...in the areas of Alzheimer's disease and neurodegenerative disease therapeutics and diagnostics, novel treatments for benign prostatic hyperplasia and other ... Business Wire (press release),
Benefits of Lycopene Mar 1, 2005
...recommend including several servings of tomatoes per week, to prevent many diseases, including cardiovascular disease, benign prostatic hyperplasia and others. ... eDiets.com,
Study Results Show Efficacy of Bioforce’s Prostasan Feb 28, 2005
...the efficacy of a certified organic saw palmetto formula, Prostasan, in addressing mild, moderate and severe benign prostatic hyperplasia (BPH), concluding ... NPIcenter (press release),
Recordati: 2004 Accounts Approved by the Board. Dividend +17%. ... Mar 4, 2005
...for the pan-European development and marketing of silodosin, a drug indicated for the treatment of symptoms associated with benign prostatic hyperplasia. ... PharmaLive.com (press release),
Weekly Calendar Mar 7, 2005
EB. Tues., March 15, 2 pm "Sexually Transmitted Infections and Prostatitis in the Etiology of Prostate Cancer and Benign Prostatic Hyperplasia," an Epidemiology ... Johns Hopkins Gazette,
Health Discovery Corporation Announces Completion of Private ... Mar 9, 2005
...validation phase of the newly discovered, patent protected biomarkers for clinically significant prostate cancer and BPH (Benign Prostatic Hyperplasia) at MD ... Market Wire (press release)
$242m Scam: Court Insists On Nwude's Full Examination Feb 16, 2005
No. 460933, was diagnosed with Benign Prostatic Hyperplasia and Chronic Prostatitis, while he complained of Haematuria. Stating ... AllAfrica.com,
Archives: The following articles may no longer be available on the web. If you want to inquire on a particular article, please contact the source publication (listed in parentheses).
Sexual sysfunction in benign prostatic hyperplasia (BPH) twice as ... May 11, 2004
The incidence of sexual dysfunction in patients suffering from Benign Prostatic Hyperplasia (BPH) -- or enlarged prostate -- is nearly twice as high as ... New-Medical.net
FDA Approves PROSCAR® Combined With Doxazosin to Reduce the Risk ... May 20, 2004
PROSCAR administered in combination with the alpha-blocker doxazosin is indicated to reduce the risk of the symptoms of benign prostatic hyperplasia (BPH), or ... Medical News Today
Study Evaluates Onset of Symptom Improvement for AVODART(TM) ( ... May 11, 2004
...the dual 5 alpha-reductase inhibitor (5ARI), may provide faster onset of symptom improvement for patients with benign prostatic hyperplasia (BPH) -- or ... PR Newswire (press release) - May 11, 2004
... the dual 5 alpha-reductase inhibitor (5ARI), may provide faster onset of symptom improvement for patients with benign prostatic hyperplasia (BPH) -- or ...
Study Evaluates Onset of Symptom Improvement for Avodart ( ... Medical News Today
Study Evaluates Onset of Symptom Improvement for Avodart ( ... May 12, 2004
Avodart, the dual 5 alpha-reductase inhibitor (5ARI), may provide faster onset of symptom improvement for patients with benign prostatic hyperplasia (BPH)--or ... Medical News Today
Botox shows promise as an alternative treatment for benign ... May 11, 2004
...of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a ... New-Medical.net
New options for prostate treatment May 20, 2004
...race is on among pharmaceutical companies, surgical-equipment makers and researchers to deliver new treatments for benign prostatic hyperplasia, the medical ... San Francisco Chronicle
Controversies and Clear Thinking May 17, 2004
...risk. It also stimulates the prostate, which may increases the risk of benign prostatic hyperplasia (BPH) and prostate cancer. Should ... Newsweek
Results of Urologix' New Cooled ThermoCath Multi-Center Study ... May 18, 2004
...announced that the 1-year results of a multi-center trial with its newest microwave technology for the treatment of benign prostatic hyperplasia (BPH) were ... Business Wire (press release) - May 18, 2004
... announced that the 1-year results of a multi-center trial with its newest microwave technology for the treatment of benign prostatic hyperplasia (BPH) were ...
Celsion Presents BPH Study Results at 99th Annual American ... Business Wire (press release) - May 11, 2004
... Dr. David Bock will be presenting two papers relating to its Prolieve(TM) Thermodilatation system for the treatment of Benign Prostatic Hyperplasia (BPH) at ...
87% of Patients Not Responding to Herbal Treatments for Urinary ... Yahoo News (press release) - May 11, 2004
... May 11 /PRNewswire/ -- Results of a European post-marketing study of 3,322 men suffering from the signs and symptoms of benign prostatic hyperplasia (BPH), who ...
AEterna/Zentaris to Present Detailed Positive Phase II Data on ... Yahoo News (press release) - May 17, 2004
... positive Phase II data on cetrorelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in endometriosis and benign prostatic hyperplasia (BPH) during ...
Natraceutical looks to men's health marketFood Navigator
Celsion Presents BPH Study Results at 99th Annual American ... May 11, 2004
Dr. David Bock will be presenting two papers relating to its Prolieve(TM) Thermodilatation system for the treatment of Benign Prostatic Hyperplasia (BPH) at ... Business Wire (press release) - May 11, 2004
... Dr. David Bock will be presenting two papers relating to its Prolieve(TM) Thermodilatation system for the treatment of Benign Prostatic Hyperplasia (BPH) at ...
87% of Patients Not Responding to Herbal Treatments for Urinary ... Yahoo News (press release) - May 11, 2004
... May 11 /PRNewswire/ -- Results of a European post-marketing study of 3,322 men suffering from the signs and symptoms of benign prostatic hyperplasia (BPH), who ...
AEterna/Zentaris to Present Detailed Positive Phase II Data on ... Yahoo News (press release) - May 17, 2004
... positive Phase II data on cetrorelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in endometriosis and benign prostatic hyperplasia (BPH) during ...
Natraceutical looks to men's health marketFood Navigator
87% of Patients Not Responding to Herbal Treatments for Urinary ... May 11, 2004
May 11 /PRNewswire/ -- Results of a European post-marketing study of 3,322 men suffering from the signs and symptoms of benign prostatic hyperplasia (BPH), who ... Yahoo News (press release) - May 11, 2004
... May 11 /PRNewswire/ -- Results of a European post-marketing study of 3,322 men suffering from the signs and symptoms of benign prostatic hyperplasia (BPH), who ...
AEterna/Zentaris to Present Detailed Positive Phase II Data on ... Yahoo News (press release) - May 17, 2004
... positive Phase II data on cetrorelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in endometriosis and benign prostatic hyperplasia (BPH) during ...
Natraceutical looks to men's health marketFood Navigator
AEterna/Zentaris to Present Detailed Positive Phase II Data on ... May 17, 2004
...positive Phase II data on cetrorelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in endometriosis and benign prostatic hyperplasia (BPH) during ... Yahoo News (press release) - May 17, 2004
... positive Phase II data on cetrorelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in endometriosis and benign prostatic hyperplasia (BPH) during ...
Natraceutical looks to men's health marketFood Navigator
Natraceutical looks to men's health market May 19, 2004
The extract will be marketed as a means of fighting benign prostatic hyperplasia (BPH), a chronic disease that affects half of all men over the age of 60 ... Food Navigator
The Journal of Urology Publishes Pioneering Study Showing ... May 18, 2004
...to cure incontinence, abnormal uterine bleeding, erectile dysfunction and urinary obstructions caused primarily by benign prostatic hyperplasia or strictures. ... Business Wire (press release) - May 18, 2004
... to cure incontinence, abnormal uterine bleeding, erectile dysfunction and urinary obstructions caused primarily by benign prostatic hyperplasia or strictures. ...
Serum PSA Losing Value as Prostate Cancer BiomarkerMedscape - May 12, 2004
... elevated PSA was highly related to prostate cancer, but it has since declined and, since 1998, has become only related to benign prostatic hyperplasia." He is ...
Concomitant Use of Sildenafil (Viagra(R)) for Erectile ... Yahoo News (press release) - May 11, 2004
SAN FRANCISCO, May 11 /PRNewswire/ -- In men being treated with an alpha-blocker for benign prostatic hyperplasia (BPH) while also receiving sildenafil citrate ...
Sexual Dysfunction in BPH Twice as High as Physicians Estimate, ... PR Newswire (press release) - May 11, 2004
... SAN FRANCISCO, May 11 /PRNewswire-FirstCall/ -- The incidence of sexual dysfunction in patients suffering from Benign Prostatic Hyperplasia (BPH) -- or ...
Concomitant Use of Sildenafil (Viagra(R)) for Erectile ... PR Newswire (press release) - May 11, 2004
... Safety Evaluation Presented SAN FRANCISCO, May 11 /PRNewswire/ -- In men being treated with an alpha-blocker for benign prostatic hyperplasia (BPH) while also ...
AEterna/Zentaris and Solvay Report Headline Positive Data from ... PR Newswire (press release) - Apr 29, 2004
... hormone (LHRH) antagonist, in three different indications: endometriosis, pre-surgical treatment of uterine myomas and benign prostatic hyperplasia (BPH), that ...
Botox has promise as prostate treatmentThe Globe and Mail
Serum PSA Losing Value as Prostate Cancer Biomarker May 12, 2004
...elevated PSA was highly related to prostate cancer, but it has since declined and, since 1998, has become only related to benign prostatic hyperplasia." He is ... Medscape - May 12, 2004
... elevated PSA was highly related to prostate cancer, but it has since declined and, since 1998, has become only related to benign prostatic hyperplasia." He is ...
Concomitant Use of Sildenafil (Viagra(R)) for Erectile ... Yahoo News (press release) - May 11, 2004
SAN FRANCISCO, May 11 /PRNewswire/ -- In men being treated with an alpha-blocker for benign prostatic hyperplasia (BPH) while also receiving sildenafil citrate ...
Sexual Dysfunction in BPH Twice as High as Physicians Estimate, ... PR Newswire (press release) - May 11, 2004
... SAN FRANCISCO, May 11 /PRNewswire-FirstCall/ -- The incidence of sexual dysfunction in patients suffering from Benign Prostatic Hyperplasia (BPH) -- or ...
Concomitant Use of Sildenafil (Viagra(R)) for Erectile ... PR Newswire (press release) - May 11, 2004
... Safety Evaluation Presented SAN FRANCISCO, May 11 /PRNewswire/ -- In men being treated with an alpha-blocker for benign prostatic hyperplasia (BPH) while also ...
AEterna/Zentaris and Solvay Report Headline Positive Data from ... PR Newswire (press release) - Apr 29, 2004
... hormone (LHRH) antagonist, in three different indications: endometriosis, pre-surgical treatment of uterine myomas and benign prostatic hyperplasia (BPH), that ...
Botox has promise as prostate treatmentThe Globe and Mail
Concomitant Use of Sildenafil (Viagra(R)) for Erectile ... May 11, 2004
SAN FRANCISCO, May 11 /PRNewswire/ -- In men being treated with an alpha-blocker for benign prostatic hyperplasia (BPH) while also receiving sildenafil citrate ... Yahoo News (press release) - May 11, 2004
SAN FRANCISCO, May 11 /PRNewswire/ -- In men being treated with an alpha-blocker for benign prostatic hyperplasia (BPH) while also receiving sildenafil citrate ...
Sexual Dysfunction in BPH Twice as High as Physicians Estimate, ... PR Newswire (press release) - May 11, 2004
... SAN FRANCISCO, May 11 /PRNewswire-FirstCall/ -- The incidence of sexual dysfunction in patients suffering from Benign Prostatic Hyperplasia (BPH) -- or ...
Concomitant Use of Sildenafil (Viagra(R)) for Erectile ... PR Newswire (press release) - May 11, 2004
... Safety Evaluation Presented SAN FRANCISCO, May 11 /PRNewswire/ -- In men being treated with an alpha-blocker for benign prostatic hyperplasia (BPH) while also ...
AEterna/Zentaris and Solvay Report Headline Positive Data from ... PR Newswire (press release) - Apr 29, 2004
... hormone (LHRH) antagonist, in three different indications: endometriosis, pre-surgical treatment of uterine myomas and benign prostatic hyperplasia (BPH), that ...
Botox has promise as prostate treatmentThe Globe and Mail
Sexual Dysfunction in BPH Twice as High as Physicians Estimate, ... May 11, 2004
SAN FRANCISCO, May 11 /PRNewswire-FirstCall/ -- The incidence of sexual dysfunction in patients suffering from Benign Prostatic Hyperplasia (BPH) -- or ... PR Newswire (press release) - May 11, 2004
... SAN FRANCISCO, May 11 /PRNewswire-FirstCall/ -- The incidence of sexual dysfunction in patients suffering from Benign Prostatic Hyperplasia (BPH) -- or ...
Concomitant Use of Sildenafil (Viagra(R)) for Erectile ... PR Newswire (press release) - May 11, 2004
... Safety Evaluation Presented SAN FRANCISCO, May 11 /PRNewswire/ -- In men being treated with an alpha-blocker for benign prostatic hyperplasia (BPH) while also ...
AEterna/Zentaris and Solvay Report Headline Positive Data from ... PR Newswire (press release) - Apr 29, 2004
... hormone (LHRH) antagonist, in three different indications: endometriosis, pre-surgical treatment of uterine myomas and benign prostatic hyperplasia (BPH), that ...
Botox has promise as prostate treatmentThe Globe and Mail
Concomitant Use of Sildenafil (Viagra(R)) for Erectile ... May 11, 2004
Safety Evaluation Presented SAN FRANCISCO, May 11 /PRNewswire/ -- In men being treated with an alpha-blocker for benign prostatic hyperplasia (BPH) while also ... PR Newswire (press release) - May 11, 2004
... Safety Evaluation Presented SAN FRANCISCO, May 11 /PRNewswire/ -- In men being treated with an alpha-blocker for benign prostatic hyperplasia (BPH) while also ...
AEterna/Zentaris and Solvay Report Headline Positive Data from ... PR Newswire (press release) - Apr 29, 2004
... hormone (LHRH) antagonist, in three different indications: endometriosis, pre-surgical treatment of uterine myomas and benign prostatic hyperplasia (BPH), that ...
Botox has promise as prostate treatmentThe Globe and Mail
AEterna/Zentaris and Solvay Report Headline Positive Data from ... Apr 29, 2004
...hormone (LHRH) antagonist, in three different indications: endometriosis, pre-surgical treatment of uterine myomas and benign prostatic hyperplasia (BPH), that ... PR Newswire (press release) - Apr 29, 2004
... hormone (LHRH) antagonist, in three different indications: endometriosis, pre-surgical treatment of uterine myomas and benign prostatic hyperplasia (BPH), that ...
Botox has promise as prostate treatmentThe Globe and Mail
Botox has promise as prostate treatment May 13, 2004
Benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, is one of the most common diseases affecting older men. ... The Globe and Mail
Resources from the National Cancer Institute on benign prostatic hyperplasia:
|
|
|
